Chemed Corporation Financial Statements (CHE)
|
|
|
|
Report date
|
|
|
26.02.2020 |
26.02.2021 |
28.02.2022 |
27.02.2023 |
29.02.2024 |
|
01.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 939 |
2 080 |
2 139 |
2 135 |
2 264 |
|
2 404 |
|
Operating Income, bln rub |
|
|
257.4 |
389.7 |
343.0 |
343.5 |
340.6 |
|
360.6 |
|
EBITDA, bln rub |
? |
|
311.3 |
454.9 |
411.2 |
393.4 |
403.7 |
|
392.2 |
|
Net profit, bln rub |
? |
|
219.9 |
319.5 |
268.6 |
249.6 |
272.5 |
|
293.3 |
|
|
OCF, bln rub |
? |
|
301.2 |
489.3 |
308.6 |
309.9 |
330.3 |
|
336.1 |
|
CAPEX, bln rub |
? |
|
53.0 |
58.8 |
58.7 |
57.3 |
56.9 |
|
49.2 |
|
FCF, bln rub |
? |
|
248.2 |
430.5 |
249.9 |
252.6 |
273.4 |
|
286.9 |
|
Dividend payout, bln rub
|
|
|
19.8 |
21.1 |
22.0 |
22.0 |
23.5 |
|
27.1 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
9.00% |
6.60% |
8.20% |
8.82% |
8.62% |
|
9.23% |
|
|
OPEX, bln rub |
|
|
360.0 |
311.7 |
426.8 |
421.6 |
456.0 |
|
471.8 |
|
Cost of production, bln rub |
|
|
1 321 |
1 378 |
1 369 |
1 370 |
1 526 |
|
1 540 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
4.54 |
2.36 |
1.87 |
4.58 |
3.11 |
|
3.42 |
|
|
Assets, bln rub |
|
|
1 268 |
1 435 |
1 343 |
1 442 |
1 761 |
|
1 769 |
|
Net Assets, bln rub |
? |
|
726.6 |
901.2 |
623.3 |
798.7 |
1 108 |
|
1 236 |
|
Debt, bln rub |
|
|
215.9 |
135.4 |
323.5 |
247.0 |
155.1 |
|
147.9 |
|
Cash, bln rub |
|
|
6.16 |
162.7 |
32.9 |
74.1 |
264.0 |
|
238.5 |
|
Net debt, bln rub |
|
|
209.8 |
-27.3 |
290.6 |
172.9 |
-108.8 |
|
-90.5 |
|
|
Ordinary share price, rub |
|
|
439.3 |
532.6 |
529.0 |
510.4 |
584.8 |
|
564.5 |
|
Number of ordinary shares, mln |
|
|
16.0 |
16.0 |
15.7 |
14.9 |
15.1 |
|
15.0 |
|
|
Market cap, bln rub |
|
|
7 015 |
8 498 |
8 291 |
7 620 |
8 800 |
|
8 481 |
|
EV, bln rub |
? |
|
7 224 |
8 471 |
8 581 |
7 793 |
8 692 |
|
8 391 |
|
Book value, bln rub |
|
|
23 |
205 |
-63 |
118 |
433 |
|
474 |
|
|
EPS, rub |
? |
|
13.8 |
20.0 |
17.1 |
16.7 |
18.1 |
|
19.5 |
|
FCF/share, rub |
|
|
15.5 |
27.0 |
15.9 |
16.9 |
18.2 |
|
19.1 |
|
BV/share, rub |
|
|
1.43 |
12.8 |
-4.05 |
7.88 |
28.7 |
|
31.6 |
|
|
EBITDA margin, % |
? |
|
16.1% |
21.9% |
19.2% |
18.4% |
17.8% |
|
16.3% |
|
Net margin, % |
? |
|
11.3% |
15.4% |
12.6% |
11.7% |
12.0% |
|
12.2% |
|
FCF yield, % |
? |
|
3.54% |
5.07% |
3.01% |
3.31% |
3.11% |
|
3.38% |
|
ROE, % |
? |
|
30.3% |
35.4% |
43.1% |
31.3% |
24.6% |
|
23.7% |
|
ROA, % |
? |
|
17.3% |
22.3% |
20.0% |
17.3% |
15.5% |
|
16.6% |
|
|
P/E |
? |
|
31.9 |
26.6 |
30.9 |
30.5 |
32.3 |
|
28.9 |
|
P/FCF |
|
|
28.3 |
19.7 |
33.2 |
30.2 |
32.2 |
|
29.6 |
|
P/S |
? |
|
3.62 |
4.09 |
3.88 |
3.57 |
3.89 |
|
3.53 |
|
P/BV |
? |
|
306.7 |
41.5 |
-130.7 |
64.7 |
20.3 |
|
17.9 |
|
EV/EBITDA |
? |
|
23.2 |
18.6 |
20.9 |
19.8 |
21.5 |
|
21.4 |
|
Debt/EBITDA |
|
|
0.67 |
-0.06 |
0.71 |
0.44 |
-0.27 |
|
-0.23 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
2.74% |
2.83% |
2.74% |
2.69% |
2.51% |
|
2.05% |
|
| Chemed Corporation shareholders |
